Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$65.94 - $99.04 $435,863 - $654,654
-6,610 Reduced 49.49%
6,747 $460,000
Q2 2023

Jul 10, 2023

BUY
$62.68 - $95.05 $311,644 - $472,588
4,972 Added 59.3%
13,357 $1.25 Million
Q1 2023

Jun 05, 2023

BUY
$47.19 - $70.77 $395,688 - $593,406
8,385 New
8,385 $568,000
Q2 2021

Aug 09, 2021

SELL
$93.66 - $139.27 $391,967 - $582,844
-4,185 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$116.57 - $155.01 $112,373 - $149,429
964 Added 29.93%
4,185 $551,000
Q4 2020

Feb 10, 2021

BUY
$99.61 - $142.12 $76,799 - $109,574
771 Added 31.47%
3,221 $427,000
Q3 2020

Nov 02, 2020

SELL
$72.92 - $102.01 $36,460 - $51,005
-500 Reduced 16.95%
2,450 $250,000
Q2 2020

Aug 17, 2020

BUY
$55.75 - $92.75 $164,462 - $273,612
2,950 New
2,950 $256,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Level Four Advisory Services, LLC Portfolio

Follow Level Four Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Level Four Advisory Services, LLC with notifications on news.